메뉴 건너뛰기




Volumn 2, Issue 3 SUPPL., 1996, Pages

Genetic susceptibility to chemical-induced cancers: Methodologic problems

Author keywords

[No Author keywords available]

Indexed keywords


EID: 9844237210     PISSN: 10773525     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (1)

References (10)
  • 1
    • 0021130765 scopus 로고
    • Metabolic oxidation phenotypes as markers of lung cancer susceptibility
    • Ayesh R, Idle JR, Ritchie JC, Crothers MJ, Hetzel MR. Metabolic oxidation phenotypes as markers of lung cancer susceptibility. Nature. 1984;312:169-70.
    • (1984) Nature , vol.312 , pp. 169-170
    • Ayesh, R.1    Idle, J.R.2    Ritchie, J.C.3    Crothers, M.J.4    Hetzel, M.R.5
  • 3
    • 0028236383 scopus 로고
    • Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens
    • Vineis P, Bartsch H, Caporaso N, et al. Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens. Nature. 1994;369:154-6.
    • (1994) Nature , vol.369 , pp. 154-156
    • Vineis, P.1    Bartsch, H.2    Caporaso, N.3
  • 4
    • 0028346981 scopus 로고
    • Application of reliability models to studies of biomarker validation
    • Taioli E, Kinney P, Zhitovic A, et al. Application of reliability models to studies of biomarker validation. Environ Health Perspect. 1994;102:306-9.
    • (1994) Environ Health Perspect. , vol.102 , pp. 306-309
    • Taioli, E.1    Kinney, P.2    Zhitovic, A.3
  • 5
    • 0027724048 scopus 로고
    • What does the odds ratio estimate in a case-control study?
    • Pierce N. What does the odds ratio estimate in a case-control study? Int J Epidemiol. 1993;22:1189-92.
    • (1993) Int J Epidemiol. , vol.22 , pp. 1189-1192
    • Pierce, N.1
  • 6
    • 0028060516 scopus 로고
    • Use of the prevalence ratio vs. the prevalence odds ratio as a measure of risk in cross-sectional studies
    • Axelson O, Fredriksson M, Ekberg K. Use of the prevalence ratio vs. the prevalence odds ratio as a measure of risk in cross-sectional studies. (letter). Occup Environ Med. 1994;51:574.
    • (1994) Occup Environ Med. , vol.51 , pp. 574
    • Axelson, O.1    Fredriksson, M.2    Ekberg, K.3
  • 7
    • 0019976311 scopus 로고
    • Role of N-acetyltransferase phenotypes in bladder carcinogenesis: A pharmacogenetic epidemiological approach to bladder cancer
    • Cartwright R, Ahmad RA, Barham-Hall D, et al. Role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer. Lancet. 1982;ii:842-5.
    • (1982) Lancet , vol.2 , pp. 842-845
    • Cartwright, R.1    Ahmad, R.A.2    Barham-Hall, D.3
  • 8
    • 0027289094 scopus 로고
    • N-Acetylation phenotype and genotype and risk of bladder cancer in benzidine-exposed workers
    • Hayes RB, Bi W, Rothman N, et al. N-Acetylation phenotype and genotype and risk of bladder cancer in benzidine-exposed workers. Carcinogenesis. 1993;14.675-8.
    • (1993) Carcinogenesis , vol.14 , pp. 675-678
    • Hayes, R.B.1    Bi, W.2    Rothman, N.3
  • 9
    • 0026240006 scopus 로고
    • Relevance of metabolic polymorphisms to human carcinogenesis: Evaluation of epidemiologic evidence
    • Caporaso N, Landi MT, Vineis P. Relevance of metabolic polymorphisms to human carcinogenesis: evaluation of epidemiologic evidence. Pharmacogenetics. 1991;1:4-19.
    • (1991) Pharmacogenetics , vol.1 , pp. 4-19
    • Caporaso, N.1    Landi, M.T.2    Vineis, P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.